[1] Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, et al. Depressive symptoms and 10-year risk for cardiovascular morbidity and mortality[J]. World J Biol Psychiatry, 2010, 11(6): 834-839. [2] Wongpakaran N, Wongpakaran T. Prevalence of major depressive disorders and suicide in long-term care facilities: a report from northern Thailand[J]. Psychogeriatrics, 2012, 12(1): 11-17. [3] Maes M, Galecki P, Chang YS, et al. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2011, 35(3): 676-692. [4] Kotan VO, Sarandol E, Kirhan E, et al. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2011, 35(5): 1284-1290. [5] Suda S, Katsura K, Kanamaru T, et al. Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation[J]. Eur J Pharmacol, 2013, 707(1/2/3): 26-31. [6] Almeida LE, Roby CD, Krueger BK. Increased BDNF expression in fetal brain in the valproic acid model of autism[J]. Mol Cell Neurosci, 2014, 59:57-62. [7] Yang C, Wang G, Wang H, et al. Cytoskeletal alterations in rat hippocampus following chronic unpredictable mild stress and re-exposure to acute and chronic unpredictable mild stress[J]. Behav Brain Res, 2009, 205(2): 518-524. [8] Chen L, Chen M, Wang F, et al. Antidepressant-like effects of Shuyusan in rats exposed to chronic stress: Effects on hypothalamic-pituitary-adrenal function[J]. Evid Based Complement Alternat Med, 2012, 940846. [9] Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants[J]. Psychopharmacology, 1995, 121(1): 66-72. [10]Klengel T, Binder EB. Gene-environment interactions in major depressive disorder[J]. Can J Psychiatry, 2013, 58(2): 76-83. [11]Tagliari B, dos Santos TM, Cunha AA, et al. Chronic variable stress induces oxidative stress and decreases butyryl cholinesterase activity in blood of rats[J]. J Neural Transm, 2010, 117(9): 1067-1076. [12]Krishnan V, Nestler EJ. Animal models of depression: molecular perspectives[J]. Curr Top Behav Neurosci, 2011, 7: 121-147. [13]Willner P. The validity of animal models of depression[J]. Psychopharmacology, 1984, 83(1): 1-16. [14]秦丽娟,刘丹,蒋心惠,等. 文拉法辛抗CUMS致大鼠抑郁行为涉及阻遏海马TH和TPH表达下调[J]. 中国临床药理学与治疗学, 2014, 19(4):398-403. [15]Brenes Sáenz JC, Villagra OR, Fornaguera-Trías J. Factor analysis of Forced Swimming test, Sucrose Preference test and Open Field test on enriched, social and isolated reared rats[J]. Behav Brain Res, 2006, 169(1): 57-65. [16]Yager S, Forlenza MJ, Miller GE.Depression and oxidative damage to lipids[J]. Psychoneuroendocrinology, 2010, 35(9): 1356-1362. [17]Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases[J]. Nature, 2006, 443(7113): 787-795. [18]Lee BH, Kim YK. The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment[J]. Psychiatry Investig , 2010, 7(4): 231-235. [19]Molendijk ML, Bus BA, Spinhoven P, et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment[J]. Mol Psychiatry, 2011, 16(11):1088-1095. [20]Cho GW, Kang BY, Kim KS, et al. Effects of valproic acid on the expression of trophic factors in human bone marrow mesenchymal stromal cells[J]. Neurosci Lett, 2012, 526(2):100-105. [21]Onishchenko N, Karpova N, Sabri F, et al. Long-lasting depression- like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury[J]. J Neurochem, 2008, 106(3): 1378-1387. |